13121EGP
- Active ingredient
- sofosbuvir+velpatasvir+voxilaprevir
- Strength
- 400/100/100mg
- Form
- tablet
- Manufacturer
- gilead sciences > eva pharma
- Route
- oral.solid
Uses
Direct-acting antiviral combination used for chronic hepatitis C infection in specific previously treated patients.
Do not use if
Concomitant use with rifampin and hypersensitivity to product components.
Side effects
Headache, fatigue, nausea, diarrhea, and serious bradycardia with amiodarone may occur.
Warnings
Screen for hepatitis B before treatment due to risk of viral reactivation.
How it works
Combines NS5B, NS5A, and NS3/4A inhibitors to suppress hepatitis C viral replication.
Storage
Store below 30°C in the original container.
